logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Healthcare Roundup – Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting, AstraZeneca’s COVID-19 vaccine is set for Indian rollout

Jan 12, 2021

Life Science

医疗保健精选——杰富瑞上调CVS药店的目标股价,软银入股生物科技公司Pacific Biosciences

Healthcare Roundup – CVS raised as Jefferies sees meaningful earning surprises; SoftBank takes stake in Pacific Biosciences

Jan 9, 2021

Life Science

Pfizer taps Dewpoint Therapeutics

Healthcare Roundup – Pfizer taps Dewpoint Therapeutics in $239M dystrophy candidate pact;Gilead’s Kite, Oxford BioTherapeutics ink immuno-oncology pact

Jan 7, 2021

Life Science

Healthcare Roundup – Moderna’s COVID-19 vaccine authorized in Israel; Moderna and NIH to study the effects of halving the COVID-19 shot

Jan 5, 2021

Life Science

Healthcare Roundup – Moderna says its vaccine gives immunity against new COVID-19 variant, AstraZeneca’s AZD1222 expected to be effective against new coronavirus strain

Dec 23, 2020

Life Science

医疗保健精选——辉瑞接近达成向美国提供更多疫苗剂量的协议;由于担心新毒株,新冠疫苗生产商面临压力

Healthcare Roundup – Pfizer nears deal to provide U.S. with more vaccine doses, Vaccines makers are under pressure amid concerns over new coronavirus strain

Dec 22, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis

Dec 22, 2020

Life Science

Healthcare Roundup – U.S. FDA gives Moderna’s COVID vaccine emergency use authorization; Pfizer/ BioNTech COVID-19 vaccine rollout reaches long-term care facilities

Dec 18, 2020

Life Science

Healthcare Roundup – Two healthcare workers suffer allergic reactions to Pfizer/BioNTech COVID-19 shot, United Airlines partners with XpresSpa for COVID-19 testing

Dec 17, 2020

Life Science

医疗保健精选——大多数美国民众可能会在2月底之前获得疫苗,吉利德Tecartus在欧洲获治疗血液癌的有条件许可

Healthcare Roundup – Most of American public may get vaccine by end of February, Gilead’s Tecartus receives conditional authorization in Europe for blood cancer

Dec 16, 2020

Life Science

Healthcare Roundup – U.S. prepares for mass inoculations as COVID-19 vaccine rolls out, Bahrain OK’s Chinese COVID-19 vaccine for use

Dec 14, 2020

Life Science

医疗保健精选——美国人可能会在周一开始接种辉瑞疫苗,COVID-19抗体疗法开发商AbCellera Bio公开募股发行价超过20美元

Healthcare Roundup – Americans could begin getting Pfizer vaccine on Monday, COVID-19 antibody therapy developer AbCellera Bio prices IPO above range at $20

Dec 11, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces Adoption of Advance Notice Bylaw and Shareholder Rights Plan as well as Transitions in its Board of Directors

Dec 11, 2020

Life Science

医疗保健精选——加拿大政府增订Moderna新冠疫苗,艾伯维Imbruvica对未经治疗的慢性淋巴细胞性白血病有显著疗效

Healthcare Roundup – Moderna’s COVID vaccine deal gets a boost from Canada, AbbVie’s Imbruvica shows treatment benefit in untreated chronic lymphocytic leukemia

Dec 7, 2020

Life Science

中国授予新冠疫苗紧急使用授权,率先面向高风险人群

China to Grant Emergency Covid-19 Vaccine Use for High-Risk Groups

Dec 3, 2020

Life Science

Healthcare Roundup – U.S. could immunize one-third of population, JD Health raises $3.5B in Hong Kong IPO

Dec 3, 2020

Life Science

医疗保健精选——英国率先授予辉瑞-BioNTech新冠疫苗紧急使用授权,美联储再购买65万剂礼来新冠抗体

Healthcare Roundup – U.K. becomes first country to authorize Pfizer-BioNTech vaccine for emergency use; Feds buy another 650K doses of Lilly COVID-19 med bamlanivimab

Dec 2, 2020

Life Science

Healthcare Roundup – Moderna’s COVID vaccine scheduled for FDA review, BioNTech -2% post-market following BofA downgrade

Dec 1, 2020

Life Science

  • ‹‹ Previous
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada